Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Accounts Payables (2016 - 2025)

Marimed (MRMD) has disclosed Accounts Payables for 15 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 10.59% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, up 10.59% year-over-year, with the annual reading at $14.6 million for FY2025, 10.59% up from the prior year.
  • Accounts Payables for Q4 2025 was $14.6 million at Marimed, up from $11.2 million in the prior quarter.
  • The five-year high for Accounts Payables was $14.6 million in Q4 2025, with the low at $4.7 million in Q1 2023.
  • Average Accounts Payables over 5 years is $9.2 million, with a median of $8.4 million recorded in 2022.
  • The sharpest move saw Accounts Payables plummeted 43.87% in 2023, then skyrocketed 119.85% in 2024.
  • Over 5 years, Accounts Payables stood at $5.1 million in 2021, then grew by 29.95% to $6.6 million in 2022, then surged by 35.84% to $9.0 million in 2023, then surged by 46.53% to $13.2 million in 2024, then rose by 10.59% to $14.6 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $14.6 million, $11.2 million, and $11.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.